Point72 Asset Management
FLGT icon

Point72 Asset Management’s Fulgent Genetics FLGT Stock Holding History

Point72 Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-236,954
Closed -$6.22M – 4023
2025
Q4 		$6.22M Sell
236,954
-134,307
-36% -$3.48M 0.01% 1676
2025
Q3 		$8.39M Sell
371,261
-173,616
-32% -$3.58M 0.01% 864
2025
Q2 		$10.8M Buy
544,877
+508,692
+1,406% +$9.92M 0.02% 703
2025
Q1 		$612K Sell
36,185
-107,428
-75% -$1.83M ﹤0.01% 1573
2024
Q4 		$2.65M Sell
143,613
-125,762
-47% -$2.46M 0.01% 1150
2024
Q3 		$5.85M Buy
+269,375
New +$6.02M 0.01% 832
2024
Q2 		– Sell
-81,800
Closed -$1.78M – 2043
2024
Q1 		$1.78M Sell
81,800
-69,513
-46% -$1.73M ﹤0.01% 1302
2023
Q4 		$4.37M Buy
151,313
+148,913
+6,205% +$3.98M 0.01% 973
2023
Q3 		$64.2K Buy
2,400
+2,387
+18,362% +$81.5K ﹤0.01% 2069
2023
Q2 		$481 Buy
+13
New +$453 ﹤0.01% 2024
2023
Q1 		– Sell
-18,800
Closed -$560K – 2336
2022
Q4 		$560K Sell
18,800
-142,121
-88% -$5.09M ﹤0.01% 1134
2022
Q3 		$6.13M Sell
160,921
-66,316
-29% -$3.32M 0.02% 648
2022
Q2 		$12.4M Buy
227,237
+163,083
+254% +$8.96M 0.05% 451
2022
Q1 		$4M Buy
64,154
+20,454
+47% +$1.35M 0.02% 750
2021
Q4 		$4.4M Sell
43,700
-180,295
-80% -$15.8M 0.02% 700
2021
Q3 		$20.1M Buy
+223,995
New +$20.4M 0.09% 304
2016
Q4 		– Sell
-80,000
Closed -$738K – 749
2016
Q3 		$738K Buy
+80,000
New +$736K 0.01% 642

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management's FLGT Position: Q1 2026 in Review

Point72 Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 236,954 shares — an estimated $6.22M sold.

Point72 Asset Management first reported a position in FLGT in Q3 2016 and held it in 17 quarters. The position peaked at $20.1M in Q3 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Point72 Asset Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 236,954 Fulgent Genetics shares in Q1 2026, an estimated $6.22M.
  • Point72 Asset Management first reported a position in Fulgent Genetics in Q3 2016 and held it in 17 quarters.
  • Point72 Asset Management's Fulgent Genetics position peaked at $20.1M in Q3 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.